Lincoln Pharmaceuticals Limited — Others, 07-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Lincoln Pharmaceuticals has submitted a certificate from its Registrar and Share Transfer Agent confirming the completion of dematerialization processes for the quarter ended June 30, 2025. This includes acceptance or rejection of securities received from depository participants, cancellation of physical certificates, and updating the ownership records with depositories within required timelines. This ensures smooth transfer and electronic holding of shares, maintaining updated shareholder records essential for transparency and efficient trading.